This website uses cookies to enhance your browsing experience, improve site performance, and gather analytics. By selecting 'Accept,' you consent to these cookies as described in our Privacy Policy.

A Feasibility RCT of Aerobika Verses ACBT in People With COPD

Sponsored by Carwyn Bridges

About this trial

Last updated 2 years ago

Study ID

21/WA/0144

Status

Recruiting

Type

Interventional

Phase

N/A

Placebo

No

Accepting

18-75 Years
40 to 90 Years
All
All

Not accepting

Not accepting
Healthy Volunteers

Trial Timing

Ended a year ago

What is this trial about?

Chronic Obstructive Pulmonary Disease (COPD) is a common preventable and treatable respiratory condition. Its main symptoms include, breathlessness, cough and frequent chest infections. Many people with COPD struggle with excessive production of sputum, resulting in more hospital admissions and worse symptoms affecting quality of life. Guidelines suggest techniques to help clear sputum but there is not strong evidence behind these. In particular we don't know how effective cough clearance techniques are and indeed if any are better than others. This study will recruit people admitted to hospital with an exacerbation of COPD who have excessive sputum and randomise them to receive a hand-held airways clearance device or chest physiotherapy exercises. We will compare symptoms, quality of life, treatment burden and hospital admissions over the following year.

What are the participation requirements?

Yes

Inclusion Criteria

- Admitted to hospital (current inpatient) or recent exacerbation treated in the community within 14 days with systemic steroids and/or antibiotics

- Male or Female, aged 40-90 years

- A diagnosis of COPD

- Greater than 10 pack year history

- FEV1 /FVC Ratio <0.70 at any time point in the last 5 years

- Regular sputum production (most days for at least 3 months)

- Prescribed optimal pharmacological treatment

- Able to provide informed consent

- CAT score >15

No

Exclusion Criteria

- Contraindications to OPEP, recent hemoptysis or pneumothorax

- Unable to use OPEP (manual dexterity)

- Unstable cardiac conditions in the opinion of the clinical team

- Life expectancy less than 12 months.

Locations

Location

Status

Recruiting